Viewing Study NCT02593851


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2025-12-25 @ 9:36 PM
Study NCT ID: NCT02593851
Status: TERMINATED
Last Update Posted: 2019-12-06
First Post: 2015-08-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection
Sponsor: Janssen Sciences Ireland UC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module